Lockheed Martin Investment Management’s Eli Lilly LLY Stock Holding History

Lockheed Martin Investment Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.7M	Sell	13,090 -1,500	-10%	-$1.53M	0.62%	40
2026 Q1	$13.4M	Buy	14,590 +2,510	+21%	+$2.54M	0.49%	43
2025 Q4	$13M	Buy	12,080 +310	+3%	+$296K	0.43%	41
2025 Q3	$8.98M	Sell	11,770 -27,400	-70%	-$20.4M	0.33%	60
2025 Q2	$30.5M	Buy	39,170 +19,800	+102%	+$15.4M	1.12%	24
2025 Q1	$16M	Sell	19,370 -3,920	-17%	-$3.26M	0.65%	39
2024 Q4	$18M	Buy	23,290 +6,510	+39%	+$5.39M	0.72%	35
2024 Q3	$14.9M	Buy	16,780 +14,280	+571%	+$12.8M	0.69%	34
2024 Q2	$2.26M	Buy	+2,500	New	+$2M	0.13%	76

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lockheed Martin Investment Management's LLY Position: Q2 2026 in Review

Lockheed Martin Investment Management reduced its Eli Lilly (LLY) stake by 10% in Q2 2026, selling an estimated $1.53M and leaving 13,090 shares worth $15.7M. The position accounts for 0.62% of the portfolio, ranked #40.

Lockheed Martin Investment Management first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $30.5M in Q2 2025. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Lockheed Martin Investment Management held 13,090 shares of Eli Lilly worth $15.7M as of Q2 2026.
Lockheed Martin Investment Management sold 1,500 Eli Lilly shares in Q2 2026, an estimated $1.53M.
Eli Lilly made up 0.62% of Lockheed Martin Investment Management's portfolio in Q2 2026, its #40 holding.
Lockheed Martin Investment Management first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
Lockheed Martin Investment Management's Eli Lilly position peaked at $30.5M in Q2 2025.
4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lockheed Martin Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.